Growth hormone treatment in Prader-Willi syndrome patients: systematic review and meta-analysis

BACKGROUND: Growth hormone (GH) treatment is currently recommended in Prader-Willi syndrome (PWS) patients. OBJECTIVES: To evaluate the impact (efficacy and safety) of the use of recombinant human GH (rhGH) as a treatment for PWS. METHOD: We performed a systematic review and, where possible, meta-an...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :BMJ Paediatr Open
Главные авторы: Passone, Caroline de Gouveia Buff, Franco, Ruth Rocha, Ito, Simone Sakura, Trindade, Evelinda, Polak, Michel, Damiani, Durval, Bernardo, Wanderley Marques
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Publishing Group 2020
Предметы:
Endocrinology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7213882/
https://ncbi.nlm.nih.gov/pubmed/32411831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjpo-2019-000630
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы